Characterization of rpoB mutations by line probe assay in rifampicin-resistant Mycobacterium tuberculosis clinical isolates from the Aegean region in Turkey

Japanese Journal of Infectious Diseases

Volumn 60, Issue 4, 2007, Pages 211-213

  Ozkutuk, Nuri ^a   Gazi, Horu ^a   Surucuoglu, Suheyla ^a   Gunduz, Ayriz ^b   Ozbakkaloglu, Beril ^a  

^a CELAL BAYAR UNIVERSITY   (Turkey)

^b Izmir Chest Diseases and Surgery Training Hospital   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTIC ACID; HISTIDINE; LEUCINE; RIFAMPICIN; RNA POLYMERASE BETA SUBUNIT; SERINE; TYROSINE; VALINE;

AMINO ACID SUBSTITUTION; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CONTROLLED STUDY; GENE FREQUENCY; GENE IDENTIFICATION; GENE MUTATION; GEOGRAPHIC DISTRIBUTION; HUMAN; IMMUNOGLOBULIN VARIABLE REGION; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; NUCLEIC ACID BASE SUBSTITUTION; TUBERCULOSIS; TURKEY (REPUBLIC);

ANTIBIOTICS, ANTITUBERCULAR; BACTERIAL PROTEINS; DRUG RESISTANCE, BACTERIAL; HUMANS; MOLECULAR DIAGNOSTIC TECHNIQUES; MUTATION; MYCOBACTERIUM TUBERCULOSIS; RIFAMPIN; TUBERCULOSIS; TURKEY;

EID: 34548416274     PISSN: 13446304     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Ramaswamy, S. and Musser, J.-M. (1998): Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update. Tuber. Lung Dis., 79, 3-29.
2. Telenti, A., Imboden, P., Marchesi, F., et al. (1993): Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis. Lancet, 341, 647-650.
3. Drobniewski, F.-A., Watterson, S.-A., Wilson, S.-M., et al. (2000): A clinical, microbiological and economic analysis of a national service for the rapid molecular diagnosis of tuberculosis and rifampicin resistance in Mycobacterium tuberculosis. J. Med. Microbiol., 49, 271-278.
4. Traore, H., Fissette, K., Bastian, I., et al. (2000): Detection of rifampicin resistance in Mycobacterium tuberculosis isolates from diverse countries by a commercial line probe assay as an initial indicator of multidrug resistance. Int. J. Tuberc. Lung Dis., 4, 481-484.
5. Ahmad, S., Araj, G.-F., Akbar, P.-K., et al. (2000): Characterization of rpoB mutations in rifampin-resistant Mycobacterium tuberculosis isolates from the Middle East. Diagn. Microbiol. Infect. Dis., 38, 227-232.
6. Rossau, R., Traore, H., De Beenhouwer, H., et al. (1997): Evaluation of the INNO-LiPA Rif. TB assay, a reverse hybridization assay for the simultaneous detection of Mycobacterium tuberculosis complex and its resistance to rifampin. Antimicrob. Agents Chemother., 41, 2093-2098.
7. Morgan, M., Kalantri, S., Flores, L., et al. (2005): A commercial line probe assay for the rapid detection of rifampicin resistance in Mycobacterium tuberculosis: a systematic review and meta-analysis. BMC Infect. Dis., 5, 62.
8. Siddiqi, S.-H. (1996): BACTEC 460TB System Product and Procedure Manual. Becton Dickinson and Company, Md., USA.
9. WHO/IUATLD Global Project on Anti-Tuberculosis Drug Resistance Surveillance (2004): Anti-Tuberculosis Drug Resistance in the World. Report number 3. World Health Organization, Geneva.
10. Surucuoglu, S., Ozkutuk, N., Celik, P., et al. (2005): Drug-resistant pulmonary tuberculosis in western Turkey: prevalence, clinical characteristics and treatment outcome. Ann. Saudi. Med., 25, 313-318.
11. Guneri, S., Unsal, I., Oztop, A., et al. (2004): The resistance rates of Mycobacterium tuberculosis strains to antituberculosis drugs: evaluation of two years' data in Aegean region, Turkey. Mikrobiyol Bul., 38, 203-212.
12. Somoskovi, A., Song, Q., Mester, J., et al. (2003): Use of molecular methods to identify the Mycobacterium tuberculosis complex (MTBC) and other mycobacterial species and to detect rifampin resistance in MTBC isolates following growth detection with the BACTEC MGIT 960 system. J. Clin. Microbiol., 41, 2822-2826.
13. Cooksey, R.-C., Morlock, G.-P., Glickman, S., et al. (1997): Evaluation of a line probe assay kit for characterization of rpoB mutations in rifampin-resistant Mycobacterium tuberculosis isolates from New York City. J. Clin. Microbiol., 35, 1281-1283.
14. Matsiota-Bernard, P., Vrioni, G. and Marinis, E. (1998): Characterization of rpoB mutations in rifampin-resistant clinical Mycobacterium tuberculosis isolates from Greece. J. Clin. Microbiol., 36, 20-23.
15. Hirano, K., Abe, C. and Takahashi, M. (1999): Mutations in the rpoB gene of rifampin-resistant Mycobacterium tuberculosis strains isolated mostly in Asian countries and their rapid detection by line probe assay. J. Clin. Microbiol., 37, 2663-2666.
16. de Oliveira, M.-M., da Silva Rocha, A., Cardoso Oelemann, M., et al. (2003): Rapid detection of resistance against rifampicin in isolates of Mycobacterium tuberculosis from Brazilian patients using a reverse-phase hybridization assay. J. Microbiol. Methods, 53, 335-342.
17. Skenders, G., Fry, A.-M., Prokopovica, I., et al. (2005): Multidrug-resistant tuberculosis detection, Latvia. Emerg. Infect. Dis., 11, 1461-1463.
18. Bartfai, Z., Somoskovi, A., Kodmon, C., et al. (2001): Molecular characterization of rifampin-resistant isolates of Mycobacterium tuberculosis from Hungary by DNA sequencing and the line probe assay J. Clin. Microbiol., 39, 3736-3739.
19. Jureen, P., Werngren, J., Hoffner, S.-E. (2004): Evaluation of the line probe assay (LiPA) for rapid detection of rifampicin resistance in Mycobacterium tuberculosis. Tuberculosis (Edinb), 84, 311-316.
20. Cavusoglu, C., Hilmioglu, S., Guneri, S., et al. (2002): Characterization of rpoB mutations in rifampin-resistant clinical isolates of Mycobacterium tuberculosis from Turkey by DNA sequencing and line probe assay. J. Clin. Microbiol., 40, 4435-4438.
21. Ahmad, S. and Mokaddas, E. (2005): The occurrence of rare rpoB mutations in rifampicin-resistant clinical Mycobacterium tuberculosis isolates from Kuwait. Int. J. Antimicrob. Agents, 26, 205-212.